中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
26期
67-68,71
,共3页
体重指数%谷丙转氨酶%脂肪肝
體重指數%穀丙轉氨酶%脂肪肝
체중지수%곡병전안매%지방간
Body mass index%Alanine aminotransferase%Fatty liver
目的:探讨健康查体者体重指数(BMI)与肝酶及脂肪肝的关系。方法选取笔者所在医院2014年1~5月的107例健康查体者,测量其身高、体重、肝功能,行肝脏彩超检查。根据BMI进行分组,对每组肝酶及脂肪肝情况进行分析。结果3组肝酶指标比较显示仅超重者和肥胖者ALT、GGT与正常组的ALT、GGT比较差异有统计学意义,其余指标比较差异无统计学意义;3组脂肪肝患者的情况比较差异均有统计学意义。结论超重者和肥胖者的ALT、GGT与正常组比较均升高,其余指标比较无异常,对于因肥胖导致的脂肪肝,ALT及GGT变化最早、最敏感,随着体重指数的增加,脂肪肝患病率越来越高,脂肪肝程度越来越严重。
目的:探討健康查體者體重指數(BMI)與肝酶及脂肪肝的關繫。方法選取筆者所在醫院2014年1~5月的107例健康查體者,測量其身高、體重、肝功能,行肝髒綵超檢查。根據BMI進行分組,對每組肝酶及脂肪肝情況進行分析。結果3組肝酶指標比較顯示僅超重者和肥胖者ALT、GGT與正常組的ALT、GGT比較差異有統計學意義,其餘指標比較差異無統計學意義;3組脂肪肝患者的情況比較差異均有統計學意義。結論超重者和肥胖者的ALT、GGT與正常組比較均升高,其餘指標比較無異常,對于因肥胖導緻的脂肪肝,ALT及GGT變化最早、最敏感,隨著體重指數的增加,脂肪肝患病率越來越高,脂肪肝程度越來越嚴重。
목적:탐토건강사체자체중지수(BMI)여간매급지방간적관계。방법선취필자소재의원2014년1~5월적107례건강사체자,측량기신고、체중、간공능,행간장채초검사。근거BMI진행분조,대매조간매급지방간정황진행분석。결과3조간매지표비교현시부초중자화비반자ALT、GGT여정상조적ALT、GGT비교차이유통계학의의,기여지표비교차이무통계학의의;3조지방간환자적정황비교차이균유통계학의의。결론초중자화비반자적ALT、GGT여정상조비교균승고,기여지표비교무이상,대우인비반도치적지방간,ALT급GGT변화최조、최민감,수착체중지수적증가,지방간환병솔월래월고,지방간정도월래월엄중。
Objective To investigate the relationship between health subjects’ body mass index (BMI) and liver en-zymes and fatty liver. Methods 107 healthy subjects of our hospital from January 2014 to May 2014 were selected. Their height,weight and liver function were measured and liver ultrasound was conducted.The healthy subjects were di-vided into groups based on BMI and the liver enzyme and fatty liver of each group were analyzed. Results Comparison of liver enzyme indicators of the three groups showed that only the ALT and GGT of the overweight and obese subjects were statistically different from the ALT and GGT of the normal group.The rest indicators were not abnormal.The three groups were statistically different in the fatty liver situation. Conclusion ALT and GGT of overweight and obese sub-jects increase compared to those of the normal group and the rest indicators are not abnormal.For obesity induced fatty liver,the changes of ALT and GGT are the earliest and most sensitive.As the body mass index increases,the prevalence rate of fatty liver rises and the severity degree of fatty liver rises.